Symposia
- Date:
- Time: -
- Track: Research
- CME/CE: 1
- Q & A: Chat
Moderator: Kathryn E. Callahan, MD, MS
Sponsored by the Medical and Surgical Specialties Section
This symposium aims to review the current state of the science in pharmacological management of type 2 diabetes mellitus (T2DM), with a particular focus on de-prescribing in alignment with the American Diabetes Association guidelines. Learning Objectives: (1) describe the risk/benefit ratios for intensive glycemic control across the heterogeneity of the older adult population; (2) review characteristics of person, place, and time that serve as effective points of transition to fuel a conversation about de-prescribing; and (3) name current technologies, and current care pathway strategies that show promise for safe and effective de-prescribing.
| De-Prescribing in T2DM: What Is It, and Why Do It? Kathryn E. Callahan, MD, MS |
| De-Prescribing in T2DM: Who, When and Where? Alexandra K. Lee, PhD, MSPH |
| De-Prescribing in T2DM: How to Do So? Current Technologies Chinenye Usoh, MD |
| De-Prescribing in T2DM: How to Do So? Interprofessional Collaborations Joshua D. Niznik, PharmD, PhD |